Results 201 to 210 of about 147,278 (254)

Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes

open access: yesCancer Science, EarlyView.
Afatinib and osimertinib showed broadly comparable survival outcomes as first‐line therapy for NSCLC with uncommon EGFR mutations. Treatment may be individualized by mutation subtype, while adding immune checkpoint inhibition to platinum doublet after EGFR‐TKI showed no clear benefit.
Yutaro Nagano   +21 more
wiley   +1 more source

Multimodality Imaging of a Pulmonary Valve Papillary Fibroelastoma Associated With Pulmonary Embolism. [PDF]

open access: yesJACC Case Rep
Tejada C   +5 more
europepmc   +1 more source

Short‐Term Complications Are Rare After Cholesteatoma Surgery

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objective To evaluate the incidence and nature of short‐term complications following cholesteatoma surgery in a heterogeneous cohort. Design A retrospective cohort study including complete coverage of cholesteatoma surgery in a Swedish region between 1 January 2005 and 31 December 2015.
Agnes Modée Borgström   +3 more
wiley   +1 more source

Correction: Acute pulmonary embolism: a paradigm shift in interventional treatment and interdisciplinary care? [PDF]

open access: yesEur Radiol
Lüdemann WM   +5 more
europepmc   +1 more source

A Challenging Pulmonary Embolism: When Acute Meets Chronic Thrombus. [PDF]

open access: yesJ Soc Cardiovasc Angiogr Interv
Lee JCY   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy